Literature DB >> 21291962

Effects of chelerythrine, a specific inhibitor of cyclooxygenase-2, on acute inflammation in mice.

Xiao-Feng Niu1, Ping Zhou, Wei-Feng Li, Hong-Bo Xu.   

Abstract

Chelerythrine (CHE), a quaternary benzo[c]phenanthridine alkaloid, which is an agent in traditional Chinese medicine exhibits a wide spectrum of pharmacological effects. In this study, we examined the anti-inflammatory activities and mechanism of CHE in vivo and in vitro, respectively. Further, in the analgesic test, CHE also showed pronounced inhibition of the acetic acid-induced writhing response. These results clearly suggested that CHE is a bioactive agent which has a significant anti-inflammatory action, which may be relevant to the inhibition of the release/production of exudates and prostaglandin E(2) mediated through cyclooxygenase-2 regulation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291962     DOI: 10.1016/j.fitote.2011.01.020

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  14 in total

1.  Chelerythrine Attenuates the Inflammation of Lipopolysaccharide-Induced Acute Lung Inflammation Through NF-κB Signaling Pathway Mediated by Nrf2.

Authors:  Lu Fan; Ye Fan; Li Liu; Weiwei Tao; Xin Shan; Yu Dong; Lin Li; Sen Zhang; Hanqing Wang
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

2.  Effect of chelerythrine against endotoxic shock in mice and its modulation of inflammatory mediators in peritoneal macrophages through the modulation of mitogen-activated protein kinase (MAPK) pathway.

Authors:  Weifeng Li; Ting Fan; Yanmin Zhang; Xiaofeng Niu; Wei Xing
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

Review 3.  Interaction of the putative anticancer alkaloid chelerythrine with nucleic acids: biophysical perspectives.

Authors:  Anirban Basu; Gopinatha Suresh Kumar
Journal:  Biophys Rev       Date:  2020-10-31

Review 4.  Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials.

Authors:  Ibrahim Jantan; Waqas Ahmad; Syed Nasir Abbas Bukhari
Journal:  Front Plant Sci       Date:  2015-08-25       Impact factor: 5.753

Review 5.  Anti-inflammatory activity of traditional Chinese medicinal herbs.

Authors:  Min-Hsiung Pan; Yi-Shiou Chiou; Mei-Ling Tsai; Chi-Tang Ho
Journal:  J Tradit Complement Med       Date:  2011-10

6.  Evaluation of anti-inflammatory and analgesic activities of extracts from herb of Chelidonium majus L.

Authors:  Przemysław Łukasz Mikołajczak; Bogdan Kędzia; Marcin Ożarowski; Radosław Kujawski; Anna Bogacz; Joanna Bartkowiak-Wieczorek; Wojciech Białas; Agnieszka Gryszczyńska; Waldemar Buchwald; Michał Szulc; Natalia Wasiak; Małgorzata Górska-Paukszta; Justyna Baraniak; Bogusław Czerny; Agnieszka Seremak-Mrozikiewicz
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

7.  Efficacy of Chelerythrine Against Mono- and Dual-Species Biofilms of Candida albicans and Staphylococcus aureus and Its Properties of Inducing Hypha-to-Yeast Transition of C. albicans.

Authors:  Weidong Qian; Jianing Zhang; Wenjing Wang; Miao Liu; Yuting Fu; Xiang Li; Ting Wang; Yongdong Li
Journal:  J Fungi (Basel)       Date:  2020-04-02

Review 8.  Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses.

Authors:  Andrew Croaker; Graham J King; John H Pyne; Shailendra Anoopkumar-Dukie; Lei Liu
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

Review 9.  Greater Celandine's Ups and Downs-21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology.

Authors:  Sylwia Zielińska; Anna Jezierska-Domaradzka; Magdalena Wójciak-Kosior; Ireneusz Sowa; Adam Junka; Adam M Matkowski
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

10.  Antibacterial mechanism of chelerythrine isolated from root of Toddalia asiatica (Linn) Lam.

Authors:  Nan He; Peiqing Wang; Pengyu Wang; Changyang Ma; Wenyi Kang
Journal:  BMC Complement Altern Med       Date:  2018-09-26       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.